Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entity

Supira Medical

Tracked across 1 events · 7 articles · First seen Apr 08, 2026 · Last active May 14, 2026

Sentiment
75
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 75
Tech
Impact: Supira Medical received FDA approval to initiate its SUPPORT II Pivotal Trial and appointed D. Keith Grossman to its Board of Directors, strengthening its position in the percutaneous ventricular assist device (pVAD) market.
Apr 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Supira Medical live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.